https://www.selleckchem.com/pr....oducts/bay-11-7085.h
onths post-randomisation. Discussion The PUrE trial aims to provide robust evidence on health status, quality of life, clinical outcomes and resource use to directly inform choice and National Health Service provision of the three treatment options. Trial registration ISRCTN ISRCTN98970319. Registered on 11 November 2015.Background Talc, a hydrous magnesium silicate, often used for genital hygiene purposes, is associated with ovarian carcinoma in case-control studies. Its potential to cause inflammation, injury, and functional chang
Respect!
Kommentar
Delen
